Related Articles
Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation
Metformin targets Axl and Tyro3 receptor tyrosine kinases to inhibit cell proliferation and overcome chemoresistance in ovarian cancer cells
Zinc oxide nanoparticles inhibit malignant progression and chemotherapy resistance of ovarian cancer cells by activating endoplasmic reticulum stress and promoting autophagy
Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway